This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blaveri, E. Articles by Waldman, F. M. Search for Related Content PubMed PubMed Citation Articles by Blaveri, E. Articles by Waldman, F. M.

Bladder Cancer Outcome and Subtype Classification by Gene Expression

Authors' Affiliations: ¹ Comprehensive Cancer Center and ² Departments of Pathology, ³ Urology, and ⁴ Laboratory Medicine, University of California at San Francisco, San Francisco, California

Requests for reprints: Frederic M. Waldman, Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA 94143-0808. Phone: 415-476-3821; Fax: 415-476-8218; E-mail: waldman{at}cc.ucsf.edu.

Models of bladder tumor progression have suggested that genetic alterations may determine both phenotype and clinical course. We have applied expression microarray analysis to a divergent set of bladder tumors to further elucidate the course of disease progression and to classify tumors into more homogeneous and clinically relevant subgroups. cDNA microarrays containing 10,368 human gene elements were used to characterize the global gene expression patterns in 80 bladder tumors, 9 bladder cancer cell lines, and 3 normal bladder samples. Robust statistical approaches accounting for the multiple testing problem were used to identify differentially expressed genes. Unsupervised hierarchical clustering successfully separated the samples into two subgroups containing superficial (pT_a and pT₁) versus muscle-invasive (pT₂-pT₄) tumors. Supervised classification had a 90.5% success rate separating superficial from muscle-invasive tumors based on a limited subset of genes. Tumors could also be classified into transitional versus squamous subtypes (89% success rate) and good versus bad prognosis (78% success rate). The performance of our stage classifiers was confirmed in silico using data from an independent tumor set. Validation of differential expression was done using immunohistochemistry on tissue microarrays for cathepsin E, cyclin A2, and parathyroid hormone–related protein. Genes driving the separation between tumor subsets may prove to be important biomarkers for bladder cancer development and progression and eventually candidates for therapeutic targeting.

Key Words: bladder cancer • expression microarrays • transitional cell carcinoma • squamous cell carcinoma

This article has been cited by other articles:

				T. Kawakubo, K. Okamoto, J.-i. Iwata, M. Shin, Y. Okamoto, A. Yasukochi, K. I. Nakayama, T. Kadowaki, T. Tsukuba, and K. Yamamoto Cathepsin E Prevents Tumor Growth and Metastasis by Catalyzing the Proteolytic Release of Soluble TRAIL from Tumor Cell Surface Cancer Res., November 15, 2007; 67(22): 10869 - 10878. [Abstract] [Full Text] [PDF]

				L. Dyrskjot, K. Zieger, F. X. Real, N. Malats, A. Carrato, C. Hurst, S. Kotwal, M. Knowles, P.-U. Malmstrom, M. de la Torre, et al. Gene Expression Signatures Predict Outcome in Non-Muscle-Invasive Bladder Carcinoma: A Multicenter Validation Study Clin. Cancer Res., June 15, 2007; 13(12): 3545 - 3551. [Abstract] [Full Text] [PDF]

				L. H. Saal, P. Johansson, K. Holm, S. K. Gruvberger-Saal, Q.-B. She, M. Maurer, S. Koujak, A. A. Ferrando, P. Malmstrom, L. Memeo, et al. Poor prognosis in carcinoma is associated with a gene expression signature of aberrant PTEN tumor suppressor pathway activity PNAS, May 1, 2007; 104(18): 7564 - 7569. [Abstract] [Full Text] [PDF]

				P. Qiu, Z. J. Wang, K. J. R. Liu, Z.-Z. Hu, and C. H. Wu Dependence network modeling for biomarker identification Bioinformatics, January 15, 2007; 23(2): 198 - 206. [Abstract] [Full Text] [PDF]

				M. A. Knowles Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese? Carcinogenesis, March 1, 2006; 27(3): 361 - 373. [Abstract] [Full Text] [PDF]

				M. Sanchez-Carbayo, N. D. Socci, J. Lozano, F. Saint, and C. Cordon-Cardo Defining Molecular Profiles of Poor Outcome in Patients With Invasive Bladder Cancer Using Oligonucleotide Microarrays J. Clin. Oncol., February 10, 2006; 24(5): 778 - 789. [Abstract] [Full Text] [PDF]